NEWS

2019

GATEWAY NEWS

October 21, 2019

GATEWAY NEWS

September 25, 2019

ARMAN NADERSHAHI INDUCTED INTO MEDICAL AND BIOLOGICAL ENGINEERING ELITE

Via AIMBE | March 28, 2019

WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Arman Nadershahi, JD, MS, MBS, MBA, Founder and CEO at Proa Medical and Sr. Director, Corporate and Intellectual Property Counsel at AMI-USC, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Mr. Nadershahi was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions to translational development of novel medical products, serial entrepreneurship, startup company formation, IP, legal, business and advocacy.”

2018

THE RACE TO DISCOVER NEW DRUGS RAMPS UP AT USC

USC Trojan Family Summer Issue 2018

Emily Gersema

MR. GARY HUTCHINSON INDUCTED INTO MEDICAL AND BIOLOGICAL ENGINEERING ELITE

Via AIMBE | April 9, 2018

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Gary E. Hutchinson, President/CEO of Biothelium, Inc., and Entrepreneur in Residence, Alfred E. Mann Institute for Biomedical Engineering, University of Southern California to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Mr. Hutchinson was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions of advocacy and commercial development for cardiology, patient safety and identification, and cancer therapeutic devices.”

BURNING TUMORS AWAY

April 9, 2018

Daniel Druhora

2017

A SUCCESSFUL MODEL FOR ACCELERATING MEDICAL INNOVATION

December 15, 2017

Ira Kalb

SoCalBio CONFERENCE SHOWCASES EMERGING TECHNOLOGY CREATED BY TROJANS

Biotech and Digital Health Companies with USC Ties Turn Out at Bioscience Event

October 2, 2017

Ron Mackovich

Harsh Vathsangam ’13 is co-founder of Moving Analytics, a company featured at the SoCalBio Conference.

Cardiopulmonary patients fare much better if they complete cardiac rehab after hospitalization, but only about a third do so. That could change, thanks to work by Harsh Vathsangam ’13 and his company, Moving Analytics, which helps patients complete much of their cardiac rehab at home with an app-based program. READ MORE

AMI-USC WILL BE A PLATINUM SPONSOR OF THE SOUTHERN CALIFORNIA BIOMEDICAL COUNCIL ANNUAL INVESTOR CONFERENCE

September 14, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that it will be a platinum sponsor of the 19th Annual SoCalBio Conference in Long Beach on September 29th.

Jon Lasch, AMI-USC’s Executive Director said, “Southern California Biomedical Council (SoCalBio) is a nonprofit, member-supported trade association that serves the biotech, medtech, IVD and digital health communities in the six counties that comprise the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino). We sponsor this conference because what they do – showcasing value-based bioscience innovations and exploring efficient pathways to bring them to market – lines up really well with what we do. It is also great to keep up with what Biomedical innovators are doing and share with them what we are doing.”

PROA MEDICAL, INC. ENTERS INTO STRATEGIC ALLIANCE AND NATIONWIDE DISTRIBUTION AGREEMENT WITH A LEADING WOMEN’S HEALTH DISTRIBUTOR

June 27, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that Proa Medical, Inc., an AMI-USC spinout company focused on women’s health medical devices, entered into a strategic alliance and nationwide distribution agreement with a leading women’s health distributor.

Arman Nadershahi, AMI-USC’s Senior Corporate and Intellectual Property Counsel, and CEO of Proa Medical, Inc., said, “We are excited to have formally entered into a long-term relationship with a preeminent distributor of obstetrical products. Our distributor has committed to investing considerable resources to market and sell Proa Medical’s innovative Brella Vaginal Retractor to hospitals throughout the US.”

The Brella Vaginal Retractor is a patented, single-use retractor with a built-in light source designed to provide optimal visualization and access during vaginal or perineal wound repair. The Brella lighted retractor separates the edges of the vagina, provides interior illumination, holds back tissue (including deep vaginal walls), and may reduce the incidence of needle stick injuries. Proa Medical, Inc. has received positive feedback from obstetricians and repeat hospital orders in its initial test launch.

About Proa Medical, Inc.

Proa Medical, Inc. provides a rapid and efficient channel to commercialize novel medical devices for women’s health that are easier to use, safer, and more efficient. As a spinout of the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (USC), the company was founded to help physician-inventors efficiently bring to market innovative, practice-enhancing technologies.

37 ºC 2017 OSLO, NORWAY CONFERENCE – JON LASCH PRESENTATION

June 6, 2017

Jon’s presentation may also be viewed here.

NANOENGINEERED STENT SURFACE TO REDUCE IN-STENT RESTENOSIS IN VIVO

June 2, 2017

VAROCTO RECEIVES APPROVAL FOR 3 PRODUCTS FROM CHINESE FDA

June 2, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that Varocto, Inc., an AMI ophthalmology spinout, received approval for 3 of its products from the Chinese equivalent of the FDA.

Winn Hong, AMI-USC’s Sr. Director for Engineering and Business Development, and Interim CEO of Varocto, said, “We are happy to report that Varocto’s products for high-resolution, non-invasive, retinal angiography have been approved by the Chinese FDA. These products include optical coherence tomography (OCT) hardware, angiography software, and a combination of the two. The products will help prevent blindness, through early diagnosis, in people with diabetic retinopathy, macular degeneration, macular edema and other potentially blinding diseases. The big news is that these products are part of a platform technology that mitigates these problems non-invasively in less than 2 minutes.”

AIMBE HAS ELECTED SEVEN FELLOWS FROM AMI-USC

May 18, 2017

AMI-USC (The Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California), a non-profit organization that bridges the gap between biomedical invention and the creation of commercially successful medical devices that save and improve people’s lives, announced today that the American Institute for Medical and Biological Engineering (AIMBE), a non-profit organization headquartered in Washington, DC that represents the top 2% of medical and biological engineers, elected seven of USC-AMI’s associates as fellows.

Jon Lasch, AMI-USC’s Executive Director said, “We are very happy and proud to report that AIMBE elected Cesar Blanco and Molly Schmid as Fellows. They join Scott Fraser, Rob Greenberg, David Hankin, Tom Lobl, and myself, who were previously elected. This is a great honor and very important since AIMBE helps to shape healthcare policy in the US and around the world.”

HELPING TO BRING LIFESAVING MEDICAL INVENTIONS TO MARKET

April 24, 2017